Thomas Lietman of the University of California, San Francisco in the U.S. will use mathematical models and cross-sectional survey data to determine the minimum number of people in a community who need to be treated for trachoma in order to halt transmission of the disease. Determining this core group can eliminate the need for mass antibiotic distribution, which results drug resistance in communities severely affected by this disease that is the leading cause of blindness.
Grant ID
OPP1015714
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False